Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
11/21/2012 | CN102784254A Chinese medicine composition assisting in reducing blood fat and preparation method of Chinese medicine composition |
11/21/2012 | CN102784247A Chitosan oligosaccharide containing medicine composition with blood fat reducing function |
11/21/2012 | CN102784237A Medicinal composition for preventing and treating diabetic complications |
11/21/2012 | CN102784230A Pharmaceutical composition preparation for treating nutritional anemia |
11/21/2012 | CN102784200A Method for extracting lignans from camphor tree leaves |
11/21/2012 | CN102784193A Method for preparing hedysarum polybotrys extract by adopting coupling technology |
11/21/2012 | CN102784185A Artificially cultivated selenium-rich radix codonopsitis and cultivating process thereof |
11/21/2012 | CN102784183A Preparation method of red ginseng polysaccharide extract product |
11/21/2012 | CN102784182A Preparation method of Radix Ginseng Rubra polysaccharide extract product |
11/21/2012 | CN102784181A Preparation method of red ginseng polysaccharide |
11/21/2012 | CN102784171A Preparation method of freeze-drying activated bionic honeycomb pollen and preparation thereof |
11/21/2012 | CN102784162A Edible fungi compound polysaccharides health care treatment preparation |
11/21/2012 | CN102784153A Super concentrated cod-liver oil and preparation method thereof |
11/21/2012 | CN102784147A Compound amino acid vitamin capsule |
11/21/2012 | CN102784139A Pharmaceutical composition for treating diabetes associated with hyperlipemia and preparation method |
11/21/2012 | CN102784137A Anti-obesity drug composition and application thereof |
11/21/2012 | CN102784127A Solid pharmaceutical composition, preparation method and application |
11/21/2012 | CN102784116A High-dissolution fenofibrate dispersible tablet and preparation process thereof |
11/21/2012 | CN102784106A Oral calcitonin liposome and lyophilized preparation thereof |
11/21/2012 | CN102784103A Probucol nano-suspension prepared by using mixing micelle technology, and preparation method thereof |
11/21/2012 | CN102783652A Preparation method of natural chromium powder sugar-reducing pill |
11/21/2012 | CN102783647A Preparation method of kudzu root isoflavone powder |
11/21/2012 | CN102783646A Preparation method for kudzuvine root flavone lozenge |
11/21/2012 | CN102319275B Sunset abelmoschus flower extract, preparation and preparation method thereof |
11/21/2012 | CN102274400B Dry jewel orchid and processing method thereof |
11/21/2012 | CN102258708B Health-preserving wine and preparation method thereof |
11/21/2012 | CN102180995B Method for extracting synanthrin from jerusalem artichoke |
11/21/2012 | CN102166269B Method for extracting flavones from waste slags of citrus bergamot drink |
11/21/2012 | CN102153672B Method for extracting chondroitin sulfate |
11/21/2012 | CN102133225B Compound polyethylene glycol electrolyte pulvis and preparation method thereof |
11/21/2012 | CN102125600B Chinese medicinal composition and preparation method thereof |
11/21/2012 | CN102068700B Phenylboronic acid polyethylene glycol gel and application thereof serving as glucose-sensitive material |
11/21/2012 | CN102060910B HLA (Human Leukocyte Antigen)-A*0201 limitation CTL (Cytotoxic T Lymphocyte) epitope of zinc translocator and application thereof |
11/21/2012 | CN102008474B Application of nitidine chloride to preparation of medicament for treating autoimmune disease and graft rejection disease |
11/21/2012 | CN102008468B Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases |
11/21/2012 | CN101977615B Inhibitor for blood phosphorus level elevation |
11/21/2012 | CN101972291B Helichrysum arenarium Moench extractive as well as preparation method and application thereof |
11/21/2012 | CN101920004B Preparation and application of coconut globulin ferrous complex iron supplement agent |
11/21/2012 | CN101856471B Chinese medicinal composition for tonifying kidney and strengthening body |
11/21/2012 | CN101803799B Gypenoside-contained cigarette and manufacture method thereof |
11/21/2012 | CN101606921B Acarbose solid sustained-release preparation and preparing method thereof |
11/21/2012 | CN101407531B Use of dimer hydrolysable tannins derivative in preparing medicament and diet additive for treating obesity |
11/21/2012 | CN101406294B Dietary fiber and method of preparing dispersible tablet |
11/21/2012 | CN101272803B Agent for promoting glucagon-like peptide 1 secretion, food or drink for promoting glucagon-like peptide 1 secretion, agent for inhibiting postprandial increase in blood sugar level and food or drink |
11/20/2012 | US8314104 Method of treating diabetes |
11/20/2012 | US8314066 GH secretagogues and uses thereof |
11/20/2012 | US8313927 Ucp4 |
11/20/2012 | CA2533763C Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors |
11/20/2012 | CA2529878C Pyrazole derivative, drug composition containing the same and production intermediate therefor |
11/20/2012 | CA2492989C Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
11/20/2012 | CA2404621C Method for preparing (2s,3r,4s)-4-hydroxyisoleucine and analogues thereof |
11/15/2012 | WO2012154999A1 Methods of treating or preventing cholesterol related disorders |
11/15/2012 | WO2012154756A2 Delaying the progression of diabetes |
11/15/2012 | WO2012154679A1 Tricyclic pyrazole sulfonamide compounds and methods of making and using same |
11/15/2012 | WO2012154678A1 Tricyclic sulfonamide compounds and methods of making and using same |
11/15/2012 | WO2012154676A1 Partially saturated tricyclic compounds and methods of making and using same |
11/15/2012 | WO2012154009A2 Thienopyrimidine derivatives, pharmaceutically acceptable salts thereof, method for preparing thienopyrimidine derivatives, and pharmaceutical composition containing thienopyrimidine derivatives as active ingredients for preventing or treating diabetes-related diseases |
11/15/2012 | WO2012153796A1 Pyrimido-diazepinone compound |
11/15/2012 | WO2012153620A1 Drug, functional food, method for stabilizing target protein, fused protein, nucleic acid, and recombinant |
11/15/2012 | WO2012153616A1 Lipid membrane structure capable of imigrating to target cell and method for producing same, and method for screening for substance exhibiting effect thereof in target cell |
11/15/2012 | WO2012153191A1 Ncor1 is a physiological modulator of muscle mass and oxidative function |
11/15/2012 | WO2012153154A1 Oxetane substituted thieno pyrimidinones |
11/15/2012 | WO2012152175A1 Preparation method for insulin glargine crystal |
11/15/2012 | WO2012151958A1 Low-toxic 3-pyrazole carboxylic acid amides, preparation methods and uses thereof in manufacture of medicines as cb1 receptor inhibitors |
11/15/2012 | WO2012128582A3 A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |
11/15/2012 | WO2012127498A3 A novel herbal composition for the treatment of kidney stone and other urinary tract disorders |
11/15/2012 | WO2012125830A3 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control |
11/15/2012 | WO2012051431A3 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders |
11/15/2012 | US20120289600 Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production |
11/15/2012 | US20120289593 Methods for risk assessment, treating, and diagnosing myocardial infarction |
11/15/2012 | US20120289587 Compounds that modulate intracellular calcium |
11/15/2012 | US20120289583 Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3) |
11/15/2012 | US20120289580 Antisense modulation of ptp1b expression |
11/15/2012 | US20120289576 Process for Forming Amorphous Atorvastatin |
11/15/2012 | US20120289574 Hydrate crystals |
11/15/2012 | US20120289554 4-dimethylaminobutyric acid derivatives |
11/15/2012 | US20120289552 Aryl ureas with angiogenesis inhibiting activity |
11/15/2012 | US20120289549 New hexahydropyrroloimidazolone compounds |
11/15/2012 | US20120289542 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome |
11/15/2012 | US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide |
11/15/2012 | US20120289525 Pyrimidine ether derivatives and methods of use thereof |
11/15/2012 | US20120289520 Chemical compounds 785 |
11/15/2012 | US20120289517 Solid pharmaceutical composition for oral administration |
11/15/2012 | US20120289512 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
11/15/2012 | US20120289505 Inhibitors of diacylglycerol acyl transferase |
11/15/2012 | US20120289497 Fused pyridine derivatives |
11/15/2012 | US20120289493 Fused heterocyclic compounds as ion channel modulators |
11/15/2012 | US20120289485 Metformin Salts of Salicylic Acid and Its Congeners |
11/15/2012 | US20120289484 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same |
11/15/2012 | US20120289479 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and Cholesterol |
11/15/2012 | US20120289476 Methods for treating methylmalonic acidemia |
11/15/2012 | US20120289470 Transmucosal administration of drug compositions for treating and preventing disorders in animals |
11/15/2012 | US20120289462 Insulin preparation |
11/15/2012 | US20120289461 Protein synthesis promoter |
11/15/2012 | US20120289460 Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases |
11/15/2012 | US20120289453 Novel glp-1 compounds |
11/15/2012 | US20120289452 Compositions and methods for treating and preventing necrosis |
11/15/2012 | US20120288578 Herbal calf starter compositions |
11/15/2012 | US20120288577 Effects of xylopia aethiopica on various cardiovascular risk factors and metabolic syndrome |
11/15/2012 | US20120288576 Effects of hypodaphnis zenkeri on various cardiovascular risk factors and metabolic syndrome |